GODEL, MARTINA
GODEL, MARTINA
ONCOLOGIA
Cholesterol metabolism: At the cross road between cancer cells and immune environment
2020-01-01 Kopecka J.; Godel M.; Riganti C.
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
2021-01-01 Bieganski P.; Godel M.; Riganti C.; Kawano D.F.; Kopecka J.; Kowalski K.
Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells
2022-01-01 Przemysław Biegański, Eduard Kovalski, Noel Israel, Evgenia Dmitrieva, Damian Trzybiński, Krzysztof Woźniak, Valerije Vrček, Martina Godel, Chiara Riganti, Joanna Kopecka, Heinrich Lang, and Konrad Kowalsk
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
2022-01-01 Salaroglio, Iris C; Belisario, Dimas Carolina; Akman, Muhlis; La Vecchia, Sofia; Godel, Martina; Anobile, Dario Pasquale; Ortone, Giacomo; Digiovanni, Sabrina; Fontana, Simona; Costamagna, Costanzo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
2023-01-01 Hattinger, Claudia Maria; Salaroglio, Iris Chiara; Fantoni, Leonardo; Godel, Martina; Casotti, Chiara; Kopecka, Joanna; Scotlandi, Katia; Ibrahim, Toni; Riganti, Chiara; Serra, Massimo
Targeting mitochondrial oncometabolites: A new approach to overcome drug resistance in cancer
2021-01-01 Godel M.; Ortone G.; Anobile D.P.; Pasino M.; Randazzo G.; Riganti C.; Kopecka J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cholesterol metabolism: At the cross road between cancer cells and immune environment | 2020 | Kopecka J.; Godel M.; Riganti C. | |
| Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro | 2021 | Bieganski P.; Godel M.; Riganti C.; Kawano D.F.; Kopecka J.; Kowalski K. | |
| Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells | 2022 | Przemysław Biegański, Eduard Kovalski, Noel Israel, Evgenia Dmitrieva, Damian Trzybiński, Krzysztof Woźniak, Valerije Vrček, Martina Godel, Chiara Riganti, Joanna Kopecka, Heinrich Lang, and Konrad Kowalsk | |
| Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer | 2022 | Salaroglio, Iris C; Belisario, Dimas Carolina; Akman, Muhlis; La Vecchia, Sofia; Godel, Martina; Anobile, Dario Pasquale; Ortone, Giacomo; Digiovanni, Sabrina; Fontana, Simona; Costamagna, Costanzo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara | |
| Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma | 2023 | Hattinger, Claudia Maria; Salaroglio, Iris Chiara; Fantoni, Leonardo; Godel, Martina; Casotti, Chiara; Kopecka, Joanna; Scotlandi, Katia; Ibrahim, Toni; Riganti, Chiara; Serra, Massimo | |
| Targeting mitochondrial oncometabolites: A new approach to overcome drug resistance in cancer | 2021 | Godel M.; Ortone G.; Anobile D.P.; Pasino M.; Randazzo G.; Riganti C.; Kopecka J. |